Skip to content

Intensifying Opioid Predicament Spreads Across Europe, Britain, and the United States

Approaching International Overdose Awareness Day on August 31st, the magnitude of the opioid crisis in Europe, the UK, and the US is being brought into focus.

Deepening Opioid Epidemic Hits Europe, UK, and the United States
Deepening Opioid Epidemic Hits Europe, UK, and the United States

Intensifying Opioid Predicament Spreads Across Europe, Britain, and the United States

In a world grappling with the escalating opioid crisis, a glimmer of hope emerges as experts and policymakers alike strive to address this preventable cause of death. The World Health Organization (WHO) asserts that death following opioid overdose can be prevented if the person receives basic life support and the timely administration of the drug naloxone.

This assertion is echoed by the Centers for Disease Control and Prevention (CDC) in the United States, which recorded over 80,000 opioid overdose deaths in 2023. Opioids, a class of drugs that include prescription painkillers like morphine, fentanyl, tramadol, and methadone, as well as illegal drugs like heroin, are at the heart of this crisis.

The crisis is not confined to the United States. New synthetic opioids such as nitazenes are fueling outbreaks in Europe, causing drug-induced deaths to surge in countries like Latvia and Estonia. Misuse of opioids can lead to dependence, street use, or dangerous counterfeit drugs laced with synthetic opioids like fentanyl, a synthetic opioid up to 100 times stronger than morphine and a major contributor to the opioid crisis in the United States.

However, there is progress on the horizon. Researchers are developing non-opioid alternatives for managing severe pain. One such promising development is the world's first selective α2B-adrenoceptor antagonist, ADRIANA. This drug relieves pain without triggering respiratory depression or addiction risks and is currently undergoing clinical trials in Japan and the US.

The campaign for change stresses six guiding principles, including "Overdose can and must be prevented... Criminalizing drug use hasn't worked. Compassionate alternatives must be pursued." In 2023, the first official proposal for the availability of Naloxone in pharmacies in Germany was not explicitly attributed to a specific individual or organization. However, Pharma Deutschland was actively involved in advocating for reforms that would facilitate over-the-counter switches, making medications more accessible via pharmacies.

The opioid crisis is a leading preventable cause of death worldwide, with approximately 80% of the 600,000 drug-related deaths in 2019 being related to opioids. Stigma remains a significant barrier to addressing the opioid crisis, with advocacy groups like Metzineres in Spain calling for "safe consumption sites and wider naloxone access."

The UK has taken steps to expand access to naloxone, a life-saving drug that reverses opioid overdoses. International Overdose Awareness Day (IOAD) is marked annually on August 31, with the 2024 campaign theme being "Together We Can." The 2024 IOAD Partners' Report recorded over 1,048 events in 42 countries, reaching 134,000 people on social media and seeing 67,000 landmarks lit up in purple.

The EU's Drugs Strategy 2021-25 lists overdose prevention as a top priority, urging greater distribution of naloxone, more treatment access, and gender-sensitive approaches. As the world continues to grapple with the opioid crisis, the guiding principles of prevention, compassion, and collaboration remain the beacon of hope in the pursuit for a safer future in pain management.

Read also: